• Health & Medicine

Targeted drug delays relapse of intermediate-stage lung cancer

A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China. A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China.

19 May 2017

• Health & Medicine

Gold nanoparticles help deliver lethal one-two punch to cancer

Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a drug into the heart of cancer cells. Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a drug into the heart of cancer cells.

8 November 2016

• Health & Medicine

New research provides hope for patients with hard-to-treat breast cancer

Cancer Research UK scientists have found a new way to slow the growth of the most aggressive type of breast cancer. Cancer Research UK scientists have found a new way to slow the growth of the most aggressive type of breast cancer.

13 June 2016

• Science & Technology
• Health & Medicine

Defining cancers based on genetic ‘fingerprint’ could help personalise treatment

Doctors are closer to personalising treatment for some cancers as genetic analysis of tumours becomes more commonplace. Doctors are closer to personalising treatment for some cancers as genetic analysis of tumours becomes more commonplace.

4 June 2016

• Science & Technology
• Health & Medicine

US hospital commits to lung cancer ‘liquid biopsy’

Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer. Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer.

8 April 2016

• Health & Medicine

Scientists identify possible double whammy to attack leukaemia

Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia. Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.

7 April 2016

• Health & Medicine

New test could help select the best treatment for bowel cancer patients

A new test could help patients with advanced bowel cancer get the best treatment for their disease. A new test could help patients with advanced bowel cancer get the best treatment for their disease.

11 February 2016

• Health & Medicine

Ovarian cancer drug wins NICE approval

NICE has given the NHS the green light over a drug which can extend the lives of ovarian cancer patients. NICE has given the NHS the green light over a drug which can extend the lives of ovarian cancer patients.

11 December 2015

• Health & Medicine

Heat-activated ‘grenade’ to target cancer

Researchers have developed cancer drug-packed ‘grenades’ armed with heat sensitive triggers, allowing for treatment to be targeted directly at tumours. Researchers have developed cancer drug-packed ‘grenades’ armed with heat sensitive triggers, allowing for treatment to be targeted directly at tumours.

31 October 2015

• Health & Medicine

Men with advanced prostate cancer could benefit from ‘targeted’ drug

A small UK clinical trial has found that a drug developed to target inherited gene faults could benefit some men whose prostate cancer has spread. A small UK clinical trial has found that a drug developed to target inherited gene faults could benefit some men whose prostate cancer has spread.

28 October 2015

• Health & Medicine
• Science & Technology

Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge

A new laboratory has been opened this week in Cambridge by life sciences minister George Freeman MP A new laboratory has been opened this week in Cambridge by life sciences minister George Freeman MP

11 September 2015

• Health & Medicine

Thousands of patients missing out on targeted cancer drugs

Thousands of cancer patients are missing out on personalised treatments each year because they are not being tested to see if they might benefit from them Thousands of cancer patients are missing out on personalised treatments each year because they are not being tested to see if they might benefit from them

20 August 2015